Coronavirus Tests India’s Vaccine Makers in R&D Capability (Nikkei Asian Review)

At least six Indian pharmaceutical companies have joined the global race to develop a novel coronavirus vaccine, giving a sector better known for making generic copies of drugs a platform to show its innovative capability.

The World Health Organization has listed three Indian companies — Zydus Cadila, Serum Institute of India and Bharat Biotech — that are working on a vaccine. In addition, Hyderabad-based companies Biological E and Indian Immunologicals as well as Bangalore-based Mynvax are also involved in development. READ MORE (CACHED ARTICLE)

Similar Posts:

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Visit Us On TwitterVisit Us On FacebookVisit Us On LinkedinCheck Our FeedVisit Us On Instagram